Method for the enantioselective reduction of 8-chloro-6-oxo-octanoic acid alkyl esters
CA2337571A1
Antihistamine leukotriene combinations
DE10102629A1
Antitumor agents having antimitotic and tubulin polymerization inhibiting action, comprising new or known 2-acyl-indole derivatives or aza analogs
US2001047103A1
Process for the preparation of oxazaphosphorine-2-amines
DE10056025A1
Process for the enantioselective reduction of 8-chloro-6oxo-octanoic acid alkyl esters
DE10043509A1
Solid peptide preparations for inhalation and their manufacture
DE10040700A1
Salts of biologically active peptides, their production and use
BG104673A
Solid pharmaceutical compositions containing miltefosine for oral administration in the treatment of leishmaniasis
DE10037310A1
New indole derivatives and their use as medicines
DE10036516A1
Process for the preparation of enantiomerically pure 6,8-dihydroxyoctanoic acid esters by asymmetric catalytic hydrogenation
DE10035928A1
New heteroaryl derivatives and their use as medicines
DE10035908A1
New heteroaryl derivatives and their use as medicines
DE10035927A1
New heteroaryl derivatives and their use as medicines
DE10027968A1
Adjuvant therapy of dementia using alpha-lipoic acid or derivative, is effective in combination with antidementia or neurotransmission improving agents in improving cognitive function in e.g. Alzheimer's disease patients
DE10024451A1
Pharmaceutical dosage form for peptides, process for their preparation and use
DE10020852A1
Antitumor agents having antimitotic and tubulin polymerization inhibiting action, comprising new or known 2-acyl-indole derivatives or aza analogs
DE10007203A1
Composition for treating allergic and/or vasomotor rhinitis or allergic conjunctivitis by topical or oral administration, contains synergistic combination of non-sedating antihistamine and leukotriene antagonist
DE19962300A1
New N-benzylindolyl glyoxylic acid derivatives are useful as antitumor agents
DE19961300A1
Storage system for medicinal products in powder form and inhaler equipped with them
DE19954321A1
Facilitated administration of alpha lipoic acid or derivatives thereof
